Puma Biotechnology Inc - Common Stock (PBYI)

Puma Biotechnology is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer

The company primarily concentrates on discovering and advancing targeted cancer therapies, with a specific emphasis on developing novel drugs that can improve the outcomes for patients with various forms of cancer. Their research is centered on precision medicine, aiming to tailor treatments based on the individual characteristics of each patient's tumor, thereby enhancing efficacy and reducing side effects. Through its commitment to scientific advancement and collaboration, Puma Biotechnology seeks to address unmet medical needs in oncology and contribute to the evolution of cancer treatment.